UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000011440 |
|---|---|
| Receipt number | R000013393 |
| Scientific Title | Phase II study of panitumumab rechallenge in the third-line therapy in patients with KRAS wild-type metastatic colorectal cancer |
| Date of disclosure of the study information | 2013/08/12 |
| Last modified on | 2019/03/08 10:10:05 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/08/10 09:49:30 | ||
| 2 | Update | 2013/11/20 11:28:27 | TEL Last name of contact person Last name of contact person Institutions |
|
| 3 | Update | 2013/11/20 12:56:57 | Last name of contact person Last name of contact person |
|
| 4 | Update | 2016/11/15 13:32:19 | Key inclusion criteria |
|
| 5 | Update | 2016/11/15 13:32:58 | Name of primary person or sponsor Organization Organization |
|
| 6 | Update | 2016/11/15 13:34:02 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 7 | Update | 2018/01/17 12:03:13 | Recruitment status |
|
| 8 | Update | 2019/03/08 10:10:05 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results |
